{"log_id": 8700871919736026963, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0.012391, "average": 0.95839, "min": 0.481318}, "location": {"width": 493, "top": 138, "height": 45, "left": 139}, "words": "包括对心律失常,心力衰竭的监测以及肝功能的评价"}, {"probability": {"variance": 9.8e-05, "average": 0.988921, "min": 0.971023}, "location": {"width": 120, "top": 229, "height": 30, "left": 148}, "words": "【临床试验】"}, {"probability": {"variance": 0.006733, "average": 0.972742, "min": 0.529493}, "location": {"width": 831, "top": 257, "height": 56, "left": 185}, "words": "本品针对去势治疗失败后的 MCPC I的有效性和安全性已经在2项随机、安慰剂对照、多中"}, {"probability": {"variance": 0.002426, "average": 0.981216, "min": 0.693273}, "location": {"width": 873, "top": 304, "height": 59, "left": 144}, "words": "心期临床试验中得到证实。这2项试验排除了既往使用过酮康唑治疗和有肾上腺或脑垂体病"}, {"probability": {"variance": 1e-05, "average": 0.995682, "min": 0.990562}, "location": {"width": 90, "top": 378, "height": 28, "left": 146}, "words": "史的患者"}, {"probability": {"variance": 0, "average": 0.999525, "min": 0.999143}, "location": {"width": 62, "top": 428, "height": 25, "left": 149}, "words": "研究1"}, {"probability": {"variance": 0.00313, "average": 0.978107, "min": 0.76115}, "location": {"width": 559, "top": 456, "height": 47, "left": 149}, "words": "既往接受过多西赛化疗的转移性去势抵抗性前列腺癌患者"}, {"probability": {"variance": 0.000805, "average": 0.985324, "min": 0.869988}, "location": {"width": 832, "top": 493, "height": 55, "left": 193}, "words": "在1项随机、安慰剂对照多中心期临床试验中,在既往接受多西他赛化疗的去势抵抗"}, {"probability": {"variance": 0.011452, "average": 0.948119, "min": 0.601524}, "location": {"width": 876, "top": 539, "height": 58, "left": 151}, "words": "性前列腺瘙患者中评估本品的疗效和安全性按2:比例随机分配共1195例患者口服本品1000"}, {"probability": {"variance": 0.013442, "average": 0.947052, "min": 0.459305}, "location": {"width": 868, "top": 584, "height": 60, "left": 162}, "words": "ng每日1次联合泼尼松5mg每日2次(N二797)或口服安慰剂每1次联合泼尼松5mg每"}, {"probability": {"variance": 0.021352, "average": 0.929398, "min": 0.429858}, "location": {"width": 874, "top": 631, "height": 59, "left": 156}, "words": "日2次(N=398)被随机分配到任一组的患者将持续治疗至疾病进展(定义为PSA较基线/最"}, {"probability": {"variance": 0.012833, "average": 0.96241, "min": 0.438184}, "location": {"width": 879, "top": 678, "height": 58, "left": 152}, "words": "低值增加25%并伴有方案定文的影像学进展和症状或临床进展开始新的抗肿瘤治疗、不可耐"}, {"probability": {"variance": 0.00901, "average": 0.97699, "min": 0.384112}, "location": {"width": 875, "top": 724, "height": 57, "left": 158}, "words": "受的毒性或退出研究。本试验排除了既往接受过酮康唑治疗前列腺和有肾上腺或垂体疾病史"}, {"probability": {"variance": 7e-06, "average": 0.996037, "min": 0.992762}, "location": {"width": 66, "top": 797, "height": 27, "left": 161}, "words": "的患者"}, {"probability": {"variance": 0.014024, "average": 0.957661, "min": 0.414715}, "location": {"width": 828, "top": 816, "height": 54, "left": 205}, "words": "各组间的者人口统计学数据和基线疾病特征是均衡的患者中位年龄为69岁(3995岁)"}, {"probability": {"variance": 0.011179, "average": 0.932994, "min": 0.420446}, "location": {"width": 876, "top": 861, "height": 56, "left": 163}, "words": "种族分布为:高加索人占93.3%,黑人占3.6%亚裔1.7%其他占1.6%。89%入组患者的ECOG"}, {"probability": {"variance": 0.012383, "average": 0.954507, "min": 0.411604}, "location": {"width": 874, "top": 905, "height": 59, "left": 165}, "words": "体力状态评分0一1简明疼痛量表评分24(在前24小时报告最痛)的患者占45%。90%患者出"}, {"probability": {"variance": 0.007248, "average": 0.968419, "min": 0.542317}, "location": {"width": 878, "top": 953, "height": 58, "left": 164}, "words": "现骨转移,30%患者出现内脏转移。70%患者具有影像学疾病进展的证据,30%患者仅有PSA进"}, {"probability": {"variance": 0.013109, "average": 0.940918, "min": 0.586252}, "location": {"width": 706, "top": 1004, "height": 57, "left": 167}, "words": "展。70%息者既往接受一种细胞毒化疗方案,30%接受两种方案治疗药"}, {"probability": {"variance": 0.006902, "average": 0.976862, "min": 0.473947}, "location": {"width": 830, "top": 1047, "height": 55, "left": 213}, "words": "在发生552例死亡后按方案进行预定的中期分析,结果显示本品组急者的总生存期较安慰"}, {"probability": {"variance": 0.006152, "average": 0.957048, "min": 0.692476}, "location": {"width": 945, "top": 1078, "height": 71, "left": 170}, "words": "剂组有统计学显著改善(表5和图1在观察到775例死亡后(占最终分析计划死工数的97"}, {"probability": {"variance": 0.000158, "average": 0.991765, "min": 0.944697}, "location": {"width": 492, "top": 1152, "height": 40, "left": 174}, "words": "更新生存分析。得到结果与期中分析结果一致(表6"}, {"probability": {"variance": 0.005544, "average": 0.957832, "min": 0.676287}, "location": {"width": 925, "top": 1187, "height": 53, "left": 174}, "words": "表6:接受本品或安慰剂与泼尼松或泼尼松龙治疗患者正在接受H激动剂治疗或既往睾丸A"}, {"probability": {"variance": 0.01591, "average": 0.960668, "min": 0.416266}, "location": {"width": 434, "top": 1248, "height": 36, "left": 176}, "words": "切除术治疗的总生存期(意向治疗分析集)"}, {"probability": {"variance": 0.002902, "average": 0.934155, "min": 0.83814}, "location": {"width": 98, "top": 1285, "height": 25, "left": 691}, "words": "本品(N=79"}, {"probability": {"variance": 3.5e-05, "average": 0.994753, "min": 0.98474}, "location": {"width": 125, "top": 1281, "height": 25, "left": 900}, "words": "安慰剂N=398"}, {"probability": {"variance": 0.00076, "average": 0.984529, "min": 0.923062}, "location": {"width": 119, "top": 1315, "height": 25, "left": 342}, "words": "生存数据分析"}, {"probability": {"variance": 0.004504, "average": 0.951842, "min": 0.846966}, "location": {"width": 74, "top": 1385, "height": 24, "left": 711}, "words": "33342%"}, {"probability": {"variance": 0.01707, "average": 0.909583, "min": 0.626731}, "location": {"width": 58, "top": 1379, "height": 24, "left": 927}, "words": "219(55"}, {"probability": {"variance": 0.046584, "average": 0.873326, "min": 0.499515}, "location": {"width": 78, "top": 1395, "height": 23, "left": 185}, "words": "死亡事件"}, {"probability": {"variance": 0.000833, "average": 0.972673, "min": 0.92009}, "location": {"width": 169, "top": 1419, "height": 27, "left": 186}, "words": "中位总生存期(月"}, {"probability": {"variance": 0.007355, "average": 0.938426, "min": 0.70991}, "location": {"width": 129, "top": 1414, "height": 22, "left": 690}, "words": "1.8(14,15.4"}, {"probability": {"variance": 0.005445, "average": 0.962671, "min": 0.739224}, "location": {"width": 127, "top": 1408, "height": 24, "left": 907}, "words": "1.910.2,12.0"}, {"probability": {"variance": 0.028875, "average": 0.904863, "min": 0.506928}, "location": {"width": 121, "top": 1448, "height": 23, "left": 207}, "words": "5%置信区间〕"}, {"probability": {"variance": 0, "average": 0.999752, "min": 0.999752}, "location": {"width": 23, "top": 1498, "height": 21, "left": 199}, "words": "值"}], "language": 3}